Search in:

Clinical Ophthalmology Volume 11, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial

Ron P Gallemore1 Retina Macula Institute, Torrance, CACorrespondence[email protected]

Josh Wallsh1 Retina Macula Institute, Torrance, CA

Henry L Hudson2 Retina Centers PC, Tucson, AZ

Allen C Ho3 Wills Eye Institute, Philadelphia, PA

Richard Chace4 Eyesight Ophthalmic Services, Portsmouth, NH

Joel Pearlman5 Retinal Consultants Medical Group, Sacramento, CA, USA

Pages 223-231 | Published online: 24 Jan 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (12)

Ryo Ando, Kiriko Hirooka, Michiyuki Saito, Satoru Kase, Kousuke Noda & Susumu Ishida. (2022) Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration. Japanese Journal of Ophthalmology 67:1, pages 50-58.
Crossref

Frédéric Matonti, Jean-François Korobelnik, Corinne Dot, Vincent Gualino, Vincent Soler, Sarah Mrejen, Marie-Noëlle Delyfer, Stéphanie Baillif, Maté Streho, Pierre Gascon, Catherine Creuzot-Garcher & Laurent Kodjikian. (2022) Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis. Journal of Clinical Medicine 11:7, pages 1834.
Crossref

Xin‐Yu Zhao, Li‐Hui Meng, Sheng‐zhi Liu & You‐Xin Chen. (2021) Efficacy and safety of different agents, dosages and strategies of anti‐vascular endothelial growth factor treatment for neovascular age‐related macular degeneration: a network meta‐analysis of randomized controlled trials. Acta Ophthalmologica 99:7.
Crossref

Josh O. Wallsh & Ron P. Gallemore. (2021) Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options. Cells 10:5, pages 1049.
Crossref

Xinyu Zhao, Lihui Meng & Youxin Chen. (2021) Comparative efficacy and safety of different regimens of ranibizumab for neovascular age-related macular degeneration: a network meta-analysis of randomised controlled trials. BMJ Open 11:2, pages e040906.
Crossref

Pei-Li Yao, Jeremy Peavey & Goldis Malek. (2020) Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases. International Journal of Molecular Sciences 21:8, pages 2889.
Crossref

Lu Ye, Zhao Jiaqi, Wang Jianchao, Feng Zhaohui, Yao Liang & Zhang Xiaohui. (2020) Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis. Therapeutic Advances in Chronic Disease 11, pages 204062232095334.
Crossref

Jaycob Avaylon & Ron P Gallemore. (2019) Verteporfin Photodynamic Therapy for the Treatment of Choroidal Conditions—An Overview. US Ophthalmic Review 12:2, pages 69.
Crossref

Yang Gao, Tao Yu, Yue Zhang & Guangfu Dang. (2018) Anti-VEGF Monotherapy Versus Photodynamic Therapy and Anti-VEGF Combination Treatment for Neovascular Age-Related Macular Degeneration: A Meta-Analysis. Investigative Opthalmology & Visual Science 59:10, pages 4307.
Crossref

Andres Gonzalez & Gibran Khurshid. (2018) Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration. American Journal of Ophthalmology Case Reports 9, pages 18-22.
Crossref

Justin Hellman & Glenn Yiu. 2018. Vitreoretinal Disorders. Vitreoretinal Disorders 35 70 .

Victor M. Villegas, Timothy G. Murray, Amy C. Schefler & Charles C. Wykoff. 2018. Lasers in Dermatology and Medicine. Lasers in Dermatology and Medicine 17 32 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial

Articles from other publishers (12)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial

Citations (12)

Articles from other publishers (12)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date